The size of the Single-use Bioprocessing Market worth in Europe was USD 1.09 million in 2022 and estimated to be growing at a CAGR of 17.6%, to reach USD 2.46 billion by 2027 during the forecast period.
Single-use bioprocessing technology is a quickly developing technology that concentrates on manufacturing disposable bioprocessing equipment and accessories for producing biopharmaceutical products. Bioprocess utilizes living cells or their components such as enzymes, bacteria, and others to get the required products. The main idea behind the use of a single-use bioprocessing technique in the bioprocess is to reduce the cost of complicated steps such as cleaning, sterilization, and maintenance of steel-based bioreactor systems.
Improving R & D activities, rising popularity for disposable biopharmaceuticals, high spending ability of the region and technological development in the bioprocessing systems is driving the growth of Europe's single-use bioprocessing systems market.
However, possible environmental and economic hazards are the major factors constraining the growth of the single-use bioprocessing market. The market is showing lucrative growth potential in the forecast period and is expected to continue its growth in the years that follow.
This research report segmented and sub-segmented the Europe Single-use Bioprocessing Market into the following categories.
Regionally, Europe region is occupying second place in the global single-use bioprocessing with a most significant share of this market followed by North America. Factors such as increasing R &D activities, growing recognition for disposable biopharmaceuticals and high manufacturing capacities are majorly propelling the market growth of single-use bioprocessing.
The UK single-use bioprocessing market is currently leading the European market and predicted the same trend throughout the forecast period. The growth of the UK is primarily enhanced due to the advanced technologies for the development of bioprocessing is fueling market growth. Also, the growing stipulation for biopharmaceuticals, low floor space requirement, less water utilization are some factors propelling the market growth of single-use bioprocessing.
France, Germany and other countries are estimated to progress well during the forecast period. Development of life sciences research centre, as well as mergers and acquisitions and quick product launches of the market, are considered to fuel the market growth of single-use bioprocessing in these countries.
Notable companies dominating the Europe Single-use Bioprocessing Market Profiled in the Report are Thermo Fisher Scientific, Danaher Corporation, GE Healthcare (General Electric Company), Sartorius Stedim Biotech S.A, Merck Millipore (Merck Group), 3M Company, Eppendorf AG, Finesse Solutions, Inc., Applikon Biotechnology B.V., and Cesco Bioengineering Co., Ltd.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com